Immunotherapy Bridge • November 29 - 30, 2017
Melanoma Bridge • November 30 - December 2, 2016
Presented by Fondazione Melanoma Onlus in collaboration with the IRCCS Fondazione G. Pascale National Cancer Institute, Sidra Medical and Research Center, the Italian Association of Medical Oncology, and the Society for Immunotherapy of Cancer
The third annual Immunotherapy Bridge, which precedes Melanoma Bridge, is a scientific program focused on the application of immunotherapy, not only for melanoma, but also for cancer in general. The program will last two days this year, to reflect the increasing importance of immunotherapy in clinical practice.
Attendees are expected from all around the world and are encouraged to submit their abstracts for poster or oral presentations during the event. All accepted abstracts will be included in a scientific journal. The speaker of the abstracts selected for oral communication will be exempt from the registration fee and will be invited as speakers to Naples.
New this year, SITC is collaborating on a joint session at Immunotherapy Bridge on Evolving Topics in Cancer Immunotherapy:
Lisa H. Butterfield, PhD - University of Pittsburgh Medical Center Hillman Cancer Center
|9:30 - 9:50 a.m.
||DC Vaccine Combinations for Melanoma
Lisa H. Butterfield, PhD - University of Pittsburgh
|9:50 - 10:10 a.m.
||The Next Generation of Oncolytic Viruses for the Treatment of Melanoma
Howard Kaufman, MD, FACS - Rutgers Cancer Institute of New Jersey
|10:10 - 10:30 a.m.
||Neoantigens in Cancer Immunotherapy
Christopher A. Klebanoff, MD - Memorial Sloan Kettering Cancer Center
|10:30 - 10:50 a.m.
||Next Generation Adoptive T Cell Therapy
Chrystal M. Paulos, PhD - Medical University of South Carolina
|10:50 - 11:00 a.m.
|11:00 - 11:15 a.m.
|11:15 a.m. - 12:15 p.m.
|12:15 - 1:15 p.m.
|1:15 -1:30 p.m.
For more information or to register, visit www.melanomabridge.org.